参考文献/References:
[1].Traub J,Bergheim I,Eibisberger M,et al. Sarcopenia and liver cirrhosis-comparison of the European Working Group on Sarcopenia criteria 2010 and 2019[J]. Nutrients,2020,12(2):547.
[2].Rosenberg IH. Sarcopenia:origins and clinical relevance[J]. J Nutr,1997,127(5 Suppl):990S-991S.
[3].Picca A,Calvani R. Molecular mechanism and pathogenesis of sarcopenia:an overview[J]. Int J Mol Sci,2021,22(6):3032.
[4].Kitamura A,Seino S,Abe T,et al. Sarcopenia:prevalence,associated factors,and the risk of mortality and disability in Japanese older adults[J]. J Cachexia Sarcopenia Muscle,2021,12(1):30-38.
[5].Ata AM,Kara M,Ekiz T,et al. Reassessing sarcopenia in hypertension:STAR and ACE inhibitors excel[J]. Int J Clin Pract,2021,75(3):e13800.
[6].侯莉明,王晓明. 肌少症与老年人常见疾病关系的研究进展[J]. 中华老年医学杂志,2020,39(06):728-731.
[7].Wu X,Li X,Xu M,et al. Sarcopenia prevalence and associated factors among older Chinese population:findings from the China health and retirement longitudinal study[J]. PLoS One,2021,16(3):e0247617.
[8].Schmidt BM,Durao S,Toews I,et al. Screening strategies for hypertension[J]. Cochrane Database Syst Rev,2020,5(5):CD013212.
[9].He N,Zhang Y,Zhang L,et al. Relationship between sarcopenia and cardiovascular diseases in the elderly:an overview[J]. Front Cardiovasc Med,2021,8(12):743710.
[10].Gao K,Cao LF,Ma WZ,et al. Association between sarcopenia and cardiovascular disease among middle-aged and older adults:Findings from the China health and retirement longitudinal study[J]. EClinicalMedicine,2022,44(1):101264.
[11].Han JM,Lee MY,Lee KB,et al. Low relative skeletal muscle mass predicts incident hypertension in Korean men:a prospective cohort study[J]. J Hypertens,2020,38(11):2223-2229.
[12].Shafiee G,Keshtkar A,Soltani A,et al. Prevalence of sarcopenia in the world:a systematic review and meta- analysis of general population studies[J]. J Diabetes Metab Disord, 2017 ,16(5):21.
[13].Xin C,Sun X,Lu L,et al. Prevalence of sarcopenia in older Chinese adults:a systematic review and meta-analysis[J]. BMJ Open,2021,11(8):e041879.
[14].杨晨,何华娟,李建蒲,等. 原发性高血压合并肌少症患病率及影响因素研究[J]. 中国全科医学,2022,25(35):4381-4388.
[15].吴小雪,陈鸿桢,郑坤,等. 社区老年高血压与肌少症的相关性研究[J]. 中华全科医学,2024,22(08):1371-1375.
[16].Can B,Kara O,Kizilarslanoglu MC,et al. Serum markers of inflammation and oxidative stress in sarcopenia[J]. Aging Clin Exp Res,2017,29(4):745-752.
[17].Han P,Yu H,Ma Y,et al. The increased risk of sarcopenia in patients with cardiovascular risk factors in Suburb-Dwelling older Chinese using the AWGS definition[J]. Sci Rep,2017,7(1):9592.
[18].Quan Y,Wang C,Wang L,et al. Geriatric sarcopenia is associated with hypertension:a systematic review and meta-analysis[J]. J Clin Hypertens (Greenwich),2023,25(9):808-816.
[19].Xing E,Wan C. Prevalence of and factors associated with sarcopenia among elderly individuals with hypertension[J]. J Int Med Res,2022,50(7):3000605221110490.
[20].杜雨恬,廖欣怡,张素琼,等. 老年H型高血压病人合并肌少症情况及其影响因素研究[J]. 实用老年医学,2024,38(7):665-668,687.
[21].蒲喜霞,李维辛,马雄滨,等. 腰臀比、肌酸激酶与不同性别老年原发性高血压患者发生肌少症的关系研究[J]. 实用心脑肺血管病杂志,2025,33(1):50-55.
[22].Jurdana M,?iberna L. Sarcopenic obesity and hypertension in elderly patients:a narrative review of pathophysiology and management strategies[J]. Ann Ist Super Sanita,2023,59(3):231-239.
[23].段苗,史丽萍. 肌肉减少症研究进展[J]. 临床医学进展,2023,13(5):8836-8844.
[24].Bano G,Trevisan C,Carraro S,et al. Inflammation and sarcopenia:a systematic review and meta-analysis[J]. Maturitas,2017,96(2):10-15.
[25].Guzik TJ,Nosalski R,Maffia P,et al. Immune and inflammatory mechanisms in hypertension[J]. Nat Rev Cardiol,2024,21(6):396-416.
[26].Shokoples BG,Paradis P,Schiffrin EL. Immunological insights into hypertension:unraveling triggers and potential therapeutic avenues[J]. Hypertens Res,2024,47(8):2115-2125.
[27].Xu JP,Zeng RX,Zhang YZ,et al. Systemic inflammation markers and the prevalence of hypertension:a NHANES cross-sectional study[J]. Hypertens Res,2023,46(4):1009-1019.
[28].Mancusi C,Izzo R,di Gioia G,et al. Insulin resistance the hinge between hypertension and type 2 diabetes[J]. High Blood Press Cardiovasc Prev,2020,27(6):515-526.
[29].Martínez-Casales M,Hernanz R,Alonso MJ. Vascular and macrophage heme oxygenase-1 in hypertension:a mini-review[J]. Front Physiol,2021,12(2):643435.
[30].Bai T,Fang F,Li F,et al. Sarcopenia is associated with hypertension in older adults:a systematic review and meta-analysis[J]. BMC Geriatr,2020,20(1):279.
[31].Damluji AA,Alfaraidhy M,AlHajri N,et al. Sarcopenia and cardiovascular diseases[J]. Circulation,2023,147(20):1534-1553.
[32].Chen X,Ji Y,Liu R,et al. Mitochondrial dysfunction:roles in skeletal muscle atrophy[J]. J Transl Med,2023,21(1):503.
[33].Liao X,Han Y,He Y,et al. Natural compounds targeting mitochondrial dysfunction:emerging therapeutics for target organ damage in hypertension[J]. Front Pharmacol,2023,14(6):1209890.
[34].Martínez-Reyes I,Chandel NS. Mitochondrial TCA cycle metabolites control physiology and disease[J]. Nat Commun,2020,11(1):102.
[35].Shigehara K,Kato Y,Izumi K,et al. Relationship between testosterone and sarcopenia in older-adult men:a narrative review[J]. J Clin Med,2022,11(20):6202.
[36].Yoh K,Ikeda K,Horie K,et al. Roles of estrogen,estrogen receptors,and estrogen-related receptors in skeletal muscle:regulation of mitochondrial function[J]. Int J Mol Sci,2023,24(3):1853.
[37].Biagetti B,Puig-Domingo M. Age-related hormones changes and its impact on health status and lifespan[J]. Aging Dis,2023,14(3):605-620.
[38].刘洋,张玉超,刘元涛. 肌因子介导肌肉与器官相互作用的研究进展[J]. 青岛大学学报(医学版),2023,59(06):945-948.
[39].Kirk B,Feehan J,Lombardi G,et al. Muscle,bone,and fat crosstalk:the biological role of myokines,osteokines,and adipokines[J]. Curr Osteoporos Rep,2020,18(4):388-400.
[40].石天兵,徐红,王羚钰. 肾素血管紧张素醛固酮系统与肌少症的相关机制研究[J]. 实用老年医学,2024,38(12):1292-1296.
[41].Carneiro MAS,Franco CMC,Silva AL,et al. Resistance exercise intervention on muscular strength and power,and functional capacity in acute hospitalized older adults:a systematic review and meta-analysis of 2498 patients in 7 randomized clinical trials[J]. Geroscience,2021,43(6):2693-2705.
[42].Jin S,Kang PM. A systematic review on advances in management of oxidative stress-associated cardiovascular diseases[J]. Antioxidants (Basel),2024,13(8):923.
[43].Caulfield L,Heslop P,Walesby KE,et al. Effect of angiotensin system inhibitors on physical performance in older people - a systematic review and meta-analysis[J]. J Am Med Dir Assoc,2021,22(6):1215-1221.e2.
[44].Apolinário-Hagen J,Drüge M,Fritsche L. Cognitive behavioral therapy,mindfulness-based cognitive therapy and acceptance commitment therapy for anxiety disorders:integrating traditional with digital treatment approaches[J]. Adv Exp Med Biol,2020,1191:291-329.
[45].Mas M?. Multidisciplinary care to older patients with multiple chronic conditions:a challenge for the health system[J]. Med Clin (Barc),2019,153(3):112-114.
相似文献/References:
[1]孙林芳 朱凌燕.老年心房颤动患者抗凝服药依从性及其影响因素分析[J].心血管病学进展,2020,(9):978.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.022]
SUN Linfang,ZHU Lingyan.Compliance with Anticoagulant Medication and Its Influencing Factors in Elderly Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2020,(8):978.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.022]
[2]向军何玲李东林魏蜀亮彭泰峦彭慧.65岁以上急性主动脉壁内血肿患者临床特点及治疗[J].心血管病学进展,2021,(2):183.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.021]
[3]董小久 习玲.肌少症筛查测试与老年心力衰竭的研究进展[J].心血管病学进展,2021,(4):360.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.017]
DONG Xiaojiu,XI Ling.Research Progress on Screening Test of Sarcopenia and Heart Failure in the Elderly[J].Advances in Cardiovascular Diseases,2021,(8):360.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.017]
[4]张冰 刘珊珊 隗东方 展为红 颜阳 吴惠人.冠状动脉血运重建与老年人认知功能的研究进展[J].心血管病学进展,2022,(3):225.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
ZHANG Bing,LIU Shanshan,WEI Dongfang,et al.Association Between Coronary Revascularization and Cognitive Function in Elderly[J].Advances in Cardiovascular Diseases,2022,(8):225.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[5]高亮 芦颜美.慢性心力衰竭并发肌少症和恶病质的诊治进展[J].心血管病学进展,2023,(7):598.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.006]
GAO Liang,LU Yanmei.Diagnosis and Treatment of Chronic Heart Failure Complicated with Sarcopenia and Cachexia[J].Advances in Cardiovascular Diseases,2023,(8):598.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.006]
[6]李莹洁 周闻禄 吴镜.抗阻训练对心力衰竭合并肌少症的影响及相关机制研究进展[J].心血管病学进展,2023,(11):1005.[doi:10.16806/j.cnki.issn.1004-3934.2023.11.011]
LI Yingjie,ZHOU Wenlu,WU Jing.Effect and Related Mechanisms of Resistance Training on Heart Failure Complicated with Sarcopenia[J].Advances in Cardiovascular Diseases,2023,(8):1005.[doi:10.16806/j.cnki.issn.1004-3934.2023.11.011]
[7]李凤 曾健 吴镜 汪汉.心肺运动康复在老年肌少症合并冠心病治疗中的研究进展[J].心血管病学进展,2025,(7):629.[doi:10.16806/j.cnki.issn.1004-3934.2025.07.011]
Cardiopulmonary Exercise Rehabilitation in Treatment of Elderly P atients with Sarcopenia and Coronary Heart Disease.,E-mailwujing3052@163.comE-mail7972348@qq.com[J].Advances in Cardiovascular Diseases,2025,(8):629.[doi:10.16806/j.cnki.issn.1004-3934.2025.07.011]
[8]李莹洁 吴镜.老年肌少症与冠状动脉粥样硬化性心脏病相关性的研究进展[J].心血管病学进展,2025,(12):1081.[doi:10.16806/j.cnki.issn.1004-3934.2025.12.006]
LI Yingjie,WU Jing.Relationship Between Senile Myopenia and Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2025,(8):1081.[doi:10.16806/j.cnki.issn.1004-3934.2025.12.006]